There is virtually no activity conducted by pharmaceutical and biotechnology companies that is not monitored for compliance. Requirements such as good laboratory practices, good clinical practices, ...

Proactivity and reactivity aren’t opposing schools of thought in supply chain risk management. They’re distinct parts of a complete, holistic strategy. Historically, reactivity and proactivity in the ...

Manufacturers are under increasing pressure to deliver high-quality products while maximizing production and profitability. However, issues like equipment downtime, inefficient processes and a lack of ...